Skip to main content
. 2022 Feb 10;13:713379. doi: 10.3389/fimmu.2022.713379

Figure 4.

Figure 4

(A) Plasma TSG-6 levels between favorable outcome and unfavorable outcome groups in non-cardioembolic AIS. (B) The ROC curve of plasma TSG-6 concentration for predicting 3-month prognosis of non-cardioembolic AIS. The AUC value is 0.795 (95% CI, 0.702–0.887; P < 0.0001). (C) TSG-6-to-IL-8 ratios between favorable outcome and unfavorable outcome groups in non-cardioembolic AIS. (D) The ROC curve of TSG-6-to-IL-8 ratio for predicting 3-month-prognosis of non-cardioembolic AIS. The AUC value is 0.873 (95% CI, 0.795–0.951; P < 0.0001). The horizontal lines indicate median levels and interquartile ranges. P-values determined by the Mann–Whitney U test. AIS, acute ischemic stroke; TSG-6, tumor necrosis factor-stimulated gene-6; IL-8, interleukin-8; ROC, receiver-operator characteristic.